BUTALBITAL, ASPIRIN, AND CAFFEINE capsule

国: アメリカ合衆国

言語: 英語

ソース: NLM (National Library of Medicine)

即購入

ダウンロード 製品の特徴 (SPC)
22-09-2021

有効成分:

BUTALBITAL (UNII: KHS0AZ4JVK) (BUTALBITAL - UNII:KHS0AZ4JVK), ASPIRIN (UNII: R16CO5Y76E) (ASPIRIN - UNII:R16CO5Y76E), CAFFEINE (UNII: 3G6A5W338E) (CAFFEINE - UNII:3G6A5W338E)

から入手可能:

Actavis Pharma, Inc.

INN(国際名):

BUTALBITAL

構図:

BUTALBITAL 50 mg

投与経路:

ORAL

処方タイプ:

PRESCRIPTION DRUG

適応症:

Butalbital, Aspirin, and Caffeine Capsules, USP are indicated for the relief of the symptom complex of tension (or muscle contraction) headache. Evidence supporting the efficacy and safety of Butalbital, Aspirin, and Caffeine Capsules, USP in the treatment of multiple recurrent headaches is unavailable. Caution in this regard is required because butalbital is habit-forming and potentially abusable. Butalbital, Aspirin, and Caffeine Capsules, USP is contraindicated under the following conditions: - Hypersensitivity or intolerance to aspirin, caffeine, or butalbital. - Patients with a hemorrhagic diathesis (e.g., hemophilia, hypoprothrombinemia, von Willebrand’s disease, the thrombocytopenias, thrombasthenia and other ill-defined hereditary platelet dysfunctions, severe vitamin K deficiency and severe liver damage). - Patients with the syndrome of nasal polyps, angioedema and bronchospastic reactivity to aspirin or other nonsteroidal anti-inflammatory drugs. Anaphylactoid reactions have occurred in such patient

製品概要:

Butalbital, Aspirin, and Caffeine Capsules, USP Green cap with a yellow body. Cap is imprinted with “WATSON” in red. Body is imprinted with “3219” in red. Bottles of 100 (NDC 0591-3219-01) are supplied with child-resistant closures. Below 25°C (77°F); tight container. Protect from moisture. Rx only For all medical inquiries contact: Actavis Parsippany, NJ 07054 1-888-838-2872 Distributed By: Actavis Pharma, Inc. Parsippany, NJ 07054 Content Updated: April 2021

認証ステータス:

New Drug Application Authorized Generic

製品の特徴

                                BUTALBITAL, ASPIRIN, AND CAFFEINE- BUTALBITAL, ASPIRIN, AND
CAFFEINE CAPSULE
ACTAVIS PHARMA, INC.
----------
BUTALBITAL, ASPIRIN, AND CAFFEINE CAPSULES, USP
C-III
CONTENT UPDATED: APRIL 2021
RX ONLY
DESCRIPTION
Butalbital, Aspirin, and Caffeine Capsules, USP are supplied in
capsule form for oral
administration.
Each capsule contains the following active ingredients:
butalbital, USP . . . . . . . . .
. . . .
50 mg
aspirin, USP . . . . . . . . . . .
. . .
325 mg
caffeine, USP . . . . . . . . . .
. . . .
40 mg
Butalbital (5-allyl-5-isobutylbarbituric acid) is a short- to
intermediate-acting barbiturate.
It has the following structural formula:
C
H
N O molecular weight 224.26
Aspirin (benzoic acid, 2-(acetyloxy)-) is an analgesic, antipyretic,
and anti-inflammatory.
It has the following structural formula:
C H O molecular weight 180.16
11
16
2
3
9
8
4
Caffeine (1,3,7-trimethylxanthine) is a central nervous system
stimulant. It has the
following structural formula:
C H
N O molecular weight 194.19
_Inactive Ingredients:_ microcrystalline cellulose, pregelatinized
starch, and talc. Gelatin
capsules contain D&C Yellow No. 10, FD&C Green No. 3, and gelatin. The
capsules are
printed with edible ink containing red iron oxide.
CLINICAL PHARMACOLOGY
Pharmacologically, Butalbital, Aspirin, and Caffeine Capsules, USP
combines the analgesic
properties of aspirin with the anxiolytic and muscle relaxant
properties of butalbital.
The clinical effectiveness of Butalbital, Aspirin, and Caffeine
Capsules, USP in tension
headache has been established in double-blind, placebo-controlled,
multi-clinic trials. A
factorial design study compared Butalbital, Aspirin, and Caffeine
Capsules, USP with
each of its major components. This study demonstrated that each
component
contributes to the efficacy of Butalbital, Aspirin, and Caffeine
Capsules, USP in the
treatment of the target symptoms of tension headache (headache pain,
psychic tension,
and muscle contraction in the head, neck, and shoulder region). For
each symptom and
the symptom comple
                                
                                完全なドキュメントを読む
                                
                            

この製品に関連するアラートを検索